Review



ll 37 peptide  (InvivoGen)


Bioz Verified Symbol InvivoGen is a verified supplier
Bioz Manufacturer Symbol InvivoGen manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 95
      Buy from Supplier

    Structured Review

    InvivoGen ll 37 peptide
    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment <t>with</t> <t>LL-37</t> (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.
    Ll 37 Peptide, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 80 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ll 37 peptide/product/InvivoGen
    Average 95 stars, based on 80 article reviews
    ll 37 peptide - by Bioz Stars, 2026-02
    95/100 stars

    Images

    1) Product Images from "DnaK supports intracellular persistence of Staphylococcus xylosus and confers mechanical resilience to a human breast cancer cell line"

    Article Title: DnaK supports intracellular persistence of Staphylococcus xylosus and confers mechanical resilience to a human breast cancer cell line

    Journal: PLOS One

    doi: 10.1371/journal.pone.0341069

    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment with LL-37 (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.
    Figure Legend Snippet: (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment with LL-37 (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.

    Techniques Used:



    Similar Products

    ll 37 peptide  (InvivoGen)
    95
    InvivoGen ll 37 peptide
    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment <t>with</t> <t>LL-37</t> (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.
    Ll 37 Peptide, supplied by InvivoGen, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ll 37 peptide/product/InvivoGen
    Average 95 stars, based on 1 article reviews
    ll 37 peptide - by Bioz Stars, 2026-02
    95/100 stars
    		  Buy from Supplier
    human antimicrobial peptide ll-37 as-61302  (AnaSpec)
    90
    AnaSpec human antimicrobial peptide ll-37 as-61302
    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment <t>with</t> <t>LL-37</t> (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.
    Human Antimicrobial Peptide Ll 37 As 61302, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human antimicrobial peptide ll-37 as-61302/product/AnaSpec
    Average 90 stars, based on 1 article reviews
    human antimicrobial peptide ll-37 as-61302 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    ll-37 peptide  (Synpeptide Co Ltd)
    90
    Synpeptide Co Ltd ll-37 peptide
    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment <t>with</t> <t>LL-37</t> (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.
    Ll 37 Peptide, supplied by Synpeptide Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ll-37 peptide/product/Synpeptide Co Ltd
    Average 90 stars, based on 1 article reviews
    ll-37 peptide - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    human antimicrobial peptide ll-37  (AnaSpec)
    90
    AnaSpec human antimicrobial peptide ll-37
    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment <t>with</t> <t>LL-37</t> (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.
    Human Antimicrobial Peptide Ll 37, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human antimicrobial peptide ll-37/product/AnaSpec
    Average 90 stars, based on 1 article reviews
    human antimicrobial peptide ll-37 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    human ll 37 elisa kit  (Cusabio)
    93
    Cusabio human ll 37 elisa kit
    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment <t>with</t> <t>LL-37</t> (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.
    Human Ll 37 Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ll 37 elisa kit/product/Cusabio
    Average 93 stars, based on 1 article reviews
    human ll 37 elisa kit - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    antibacterial peptide  (Cusabio)
    93
    Cusabio antibacterial peptide
    Figure 2. CRAMP drives the expansion of lactobacilli bacteria during Emu infection. (a) ELISA measurements of <t>antibacterial</t> peptides (AMPs) in serum and colon tissue in the naive mice and mice infected with Emu 6 weeks post-infection. The expression levels were scaled between naive and infection and are shown in Z-score. (b) The protein level of CRAMP in the serum of the mice at the early or chronic infection stage. (c) The increased level of CRAMP in the feces of the mice 2 hours after injection with mCRAMP. (d and e) the abundances of Lactobacillus and Enterobacteriaceae (d) and L/E ratio (e) in the feces of the mice injected with mouse CRAMP or vehicle control. qPCR analyses were performed every two days. (f, g, and h) the abundances of Lactobacillus (f) and Enterobacteriaceae (g) and
    Antibacterial Peptide, supplied by Cusabio, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibacterial peptide/product/Cusabio
    Average 93 stars, based on 1 article reviews
    antibacterial peptide - by Bioz Stars, 2026-02
    93/100 stars
    		  Buy from Supplier
    human antimicrobial peptide ll-37 anaspec #as-61302  (AnaSpec)
    90
    AnaSpec human antimicrobial peptide ll-37 anaspec #as-61302
    Figure 2. CRAMP drives the expansion of lactobacilli bacteria during Emu infection. (a) ELISA measurements of <t>antibacterial</t> peptides (AMPs) in serum and colon tissue in the naive mice and mice infected with Emu 6 weeks post-infection. The expression levels were scaled between naive and infection and are shown in Z-score. (b) The protein level of CRAMP in the serum of the mice at the early or chronic infection stage. (c) The increased level of CRAMP in the feces of the mice 2 hours after injection with mCRAMP. (d and e) the abundances of Lactobacillus and Enterobacteriaceae (d) and L/E ratio (e) in the feces of the mice injected with mouse CRAMP or vehicle control. qPCR analyses were performed every two days. (f, g, and h) the abundances of Lactobacillus (f) and Enterobacteriaceae (g) and
    Human Antimicrobial Peptide Ll 37 Anaspec #As 61302, supplied by AnaSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human antimicrobial peptide ll-37 anaspec #as-61302/product/AnaSpec
    Average 90 stars, based on 1 article reviews
    human antimicrobial peptide ll-37 anaspec #as-61302 - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier
    ll-37 peptide  (Peptron Inc)
    90
    Peptron Inc ll-37 peptide
    Figure 2. CRAMP drives the expansion of lactobacilli bacteria during Emu infection. (a) ELISA measurements of <t>antibacterial</t> peptides (AMPs) in serum and colon tissue in the naive mice and mice infected with Emu 6 weeks post-infection. The expression levels were scaled between naive and infection and are shown in Z-score. (b) The protein level of CRAMP in the serum of the mice at the early or chronic infection stage. (c) The increased level of CRAMP in the feces of the mice 2 hours after injection with mCRAMP. (d and e) the abundances of Lactobacillus and Enterobacteriaceae (d) and L/E ratio (e) in the feces of the mice injected with mouse CRAMP or vehicle control. qPCR analyses were performed every two days. (f, g, and h) the abundances of Lactobacillus (f) and Enterobacteriaceae (g) and
    Ll 37 Peptide, supplied by Peptron Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ll-37 peptide/product/Peptron Inc
    Average 90 stars, based on 1 article reviews
    ll-37 peptide - by Bioz Stars, 2026-02
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment with LL-37 (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.

    Journal: PLOS One

    Article Title: DnaK supports intracellular persistence of Staphylococcus xylosus and confers mechanical resilience to a human breast cancer cell line

    doi: 10.1371/journal.pone.0341069

    Figure Lengend Snippet: (A) Growth of wild-type, ∆dnaK, and ∆dnaK-C strains under hypoxic conditions (1% O₂). OD₆₀₀ measurements and CFU enumeration were performed at indicated time points. (B) Survival of strains following treatment with LL-37 (10 µg/mL, 2 h). Viable CFUs were determined by plating. Data represent means ± SEM from three independent experiments. Differences among groups were analyzed by one-way ANOVA. p < 0.05; ns, not significant.

    Article Snippet: To test hypoxia tolerance, bacteria were cultured in an anaerobic chamber (1% O2, 5% CO2, balanced N2; Whitley H35 Hypoxystation) for 12 h. LL-37 peptide (InvivoGen) was used at 10 μg/mL for 1 h in PBS with 1% BSA.

    Techniques:

    Figure 2. CRAMP drives the expansion of lactobacilli bacteria during Emu infection. (a) ELISA measurements of antibacterial peptides (AMPs) in serum and colon tissue in the naive mice and mice infected with Emu 6 weeks post-infection. The expression levels were scaled between naive and infection and are shown in Z-score. (b) The protein level of CRAMP in the serum of the mice at the early or chronic infection stage. (c) The increased level of CRAMP in the feces of the mice 2 hours after injection with mCRAMP. (d and e) the abundances of Lactobacillus and Enterobacteriaceae (d) and L/E ratio (e) in the feces of the mice injected with mouse CRAMP or vehicle control. qPCR analyses were performed every two days. (f, g, and h) the abundances of Lactobacillus (f) and Enterobacteriaceae (g) and

    Journal: Gut microbes

    Article Title: Helminth reshapes host gut microbiota and immunoregulation by deploying an antimicrobial program of innate immunity.

    doi: 10.1080/19490976.2025.2496447

    Figure Lengend Snippet: Figure 2. CRAMP drives the expansion of lactobacilli bacteria during Emu infection. (a) ELISA measurements of antibacterial peptides (AMPs) in serum and colon tissue in the naive mice and mice infected with Emu 6 weeks post-infection. The expression levels were scaled between naive and infection and are shown in Z-score. (b) The protein level of CRAMP in the serum of the mice at the early or chronic infection stage. (c) The increased level of CRAMP in the feces of the mice 2 hours after injection with mCRAMP. (d and e) the abundances of Lactobacillus and Enterobacteriaceae (d) and L/E ratio (e) in the feces of the mice injected with mouse CRAMP or vehicle control. qPCR analyses were performed every two days. (f, g, and h) the abundances of Lactobacillus (f) and Enterobacteriaceae (g) and

    Article Snippet: The level of each antibacterial peptide was evaluated using ELISA methods as per the recommendation of each manufacturer, including CRAMP ELISA kit (Cat. CSB-E5061m, Cusabio), Reg3g ELISA kit (Cat. CSB-EL9549MO, Cusabio), Sprr2a ELISA kit (Cat. K8–14835, KIRbio), Lyz1 ELISA kit (Cat. K8–14839), Retnla ELISA kit (Cat. K8–02975), α-defensins ELISA kit (Cat. K6–02404, KIRbio), β-defensins ELISA kit (Cat. K6–02440, KIRbio), Reg3α ELISA kit (Cat. K6–14918, KIRbio), and human LL-37 ELISA kit (Cat. CSBEL4476HU, Cusabio).

    Techniques: Bacteria, Infection, Enzyme-linked Immunosorbent Assay, Expressing, Injection, Control